Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND6 pseudogene 20 (MTND6P20) is a nuclear-encoded pseudogene that resembles the mitochondrial ND6 gene, which encodes a subunit of NADH:ubiquinone oxidoreductase (complex I), a critical component in the mitochondrial respiratory chain[4]. As a pseudogene, MTND6P20 does not produce a functional protein and has no demonstrated biological or therapeutic relevance. Pseudogenes typically arise from duplication or retrotransposition events and are generally considered non-functional genomic elements, although some pseudogenes can be transcribed or may play regulatory roles in rare circumstances. No documented evidence links MTND6P20 itself to biological processes, disease, or drug interactions; its designation is based solely on sequence similarity to the functional mitochondrial ND6 gene[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND6 pseudogene 20 (MTND6P20).